🇺🇸 FDA
Pipeline program

Fexofenadine

M016455C_4001

Approved small_molecule completed

Quick answer

Fexofenadine for Rhinitis, Allergic, Perennial is a Approved program (small_molecule) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).

Program details

Company
Sanofi Pasteur
Indication
Rhinitis, Allergic, Perennial
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials